Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
09:29:40 EDT Wed 13 May 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:RXRX - RECURSION PHARMACEUTICALS INC - https://www.recursion.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
RXRX - Q0.43.11·3.130.43.15339.0533544    7.18  2.8009:12:55May 1115 min RT 2¢

Recent Trades - Last 10 of 544
Time ETExPriceChangeVolume
09:12:55Q3.12-0.036
09:11:27Q3.11-0.047
09:10:30Q3.1103-0.039710
09:09:31Q3.12-0.0350
09:09:31Q3.12-0.0350
09:08:49Q3.12-0.03100
09:08:06Q3.12-0.0320
09:07:04Q3.12-0.03200
09:05:34Q3.12-0.0314
09:05:22Q3.12-0.032

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-05-11 08:30U:RXRXNews ReleaseThe Future of Intoxication Detection May Be in Your Voice
2026-05-06 06:30U:RXRXNews ReleaseRecursion Reports First Quarter Financial Results and Provides Business Update
2026-04-30 16:30U:RXRXNews ReleaseRecursion Announces Board Transition
2026-04-29 07:59U:RXRXNews ReleaseRecursion to Report First Quarter 2026 Business Updates and Financial Results on May 6
2026-04-07 08:00U:RXRXNews ReleaseRecursion to Participate in Upcoming Investor Conferences
2026-03-31 09:00U:RXRXNews ReleaseRecursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform
2026-03-25 07:59U:RXRXNews ReleaseRecursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer
2026-03-05 08:30U:RXRXNews ReleasePacBio Announces the Appointment of Chris Gibson to the Board of Directors
2026-02-25 06:30U:RXRXNews ReleaseRecursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
2026-02-23 08:00U:RXRXNews ReleaseRecursion To Be Featured in HighRes' Lightning Talk at NVIDIA GTC
2026-02-23 07:55U:RXRXNews ReleaseRecursion to Participate in Upcoming Investor Conferences
2026-02-18 08:30U:RXRXNews ReleaseRecursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25
2026-02-12 07:59U:RXRXNews ReleaseRecursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
2026-01-06 07:59U:RXRXNews ReleaseRecursion to Present at 44th Annual J.P. Morgan Healthcare Conference
2025-12-08 07:30U:RXRXNews ReleasePositive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
2025-12-01 08:30U:RXRXNews ReleaseRecursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025
2025-11-18 08:45U:RXRXNews ReleaseLongevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033
2025-11-05 06:30U:RXRXNews ReleaseRecursion Reports Third Quarter 2025 Financial Results and Provides Business Update
2025-11-05 06:28U:RXRXNews ReleaseRecursion Announces CEO Transition Plan to Drive Next Phase of Growth
2025-11-04 08:00U:RXRXNews ReleaseRecursion to Participate in Upcoming Investor Conferences